DD
Delphine Diagnostics develops fast and effective sepsis diagnostic test kits utilizing real-time PCR technology for accurate pathogen and host marker detection. The company provides supplemental AI and Machine Learning software tools to support clinicians with personalized treatment decision support. Their focus is on delivering affordable, reliable diagnostic products to speed effective diagnosis and treatment for patients with infectious diseases.
Updated 14 months ago
Funding
Funding not disclosed
COIA
Funding rounds are not available yet.
Founders
Product
Features
- Delphine Diagnostics develops fast and effective sepsis diagnostic test kits utilizing real-time PCR technology for accurate pathogen and host marker detection. The company provides supplemental AI and Machine Learning software tools to support clinicians with personalized treatment decision support. Their focus is on delivering affordable, reliable diagnostic products to speed effective diagnosis and treatment for patients with infectious diseases.